Signaling pathways
-
BA3163 Thalidomide-NH-C6-NH-BocSummary: Thalidomide-NH-C6-NH-Boc is a synthetic E3 ligase ligand-ligand protein coupling compound combining ligand-based Thalidomide and ligand proteins for the synthesis of MI-389 (Compound 22). - BA3164 Thalidomide-NH-PEG2-C2-NH-BocSummary: Thalidomide-NH-PEG2-C2-NH-Boc is a synthetic E3 ligase ligand-linker coupler combining a Thalidomide-based ligand and a PEGLinker that can be used for dBRD9 (Compound 6) synthesis.
- BA3165 GGTI298Summary: GGTI298 is a potent GGTaseI inhibitor.
- BA3166 Thalidomide-O-amido-C3-PEG3-C1-NH2Summary: Thalidomide-O-amido-C3-PEG3-C1-NH2 is a synthetic E3 ligase ligand-linker coupler.
- BA3167 CMLD010509Summary: CMLD010509 (SDS-1-021) is a highly specific inhibitor that supports the oncogenic translational program in multiple myeloma (MM).
- BA3168 NevanimibeSummary: Nevanimibe (PD-132301) is an orally effective, selective acyl coenzyme A:cholesterol O-acyltransferase 1 inhibitor.
- BA3169 S2116Summary: S2116, an N-alkylated trans-cyclopropylamine (TCP) derivative, is a potent lysine-specific demethylase 1 inhibitor.
- BA3170 CantrixilSummary: Cantrixil (TRX-E-002-1) is the active enantiomer of TRX-E-002, a second generation superbenzopyran (SBP) compound.
- BA3171 S2157Summary: S2157, an N-alkylated trans-cyclopropylamine (TCP) derivative, is a potent lysine-specific demethylase 1 inhibitor.
- BA3172 Thalidomide-piperazine-BocSummary: An intermediate that can be used in the synthesis of BCL6.